Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Gemtuzumab Ozogamicin (GO) Inclusion to Induction Chemotherapy Eliminates Leukemic Initiating Cells and Significantly Improves Survival in Mouse Models of Acute Myeloid Leukemia
PaperCitations, authors & open-access status
Gemtuzumab Ozogamicin (GO) Inclusion to Induction Chemotherapy Eliminates Leukemic Initiating Cells and Significantly Improves Survival in Mouse Models of Acute Myeloid Leukemia is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 25 citations, 2017 year and gold oa status.
25
Citations
2017
Year
gold
OA Status